Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
Zur Ablage hinzufügen
  Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben
Meeting Abstract

Deuterium Metabolic Imaging of the Human Brain in vivo at 7T

MPG-Autoren
/persons/resource/persons215122

Ruhm,  L
Research Group MR Spectroscopy and Ultra-High Field Methodology, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons133464

Avdievich,  NI
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons84402

Henning,  A
Research Group MR Spectroscopy and Ultra-High Field Methodology, Max Planck Institute for Biological Cybernetics, Max Planck Society;

Externe Ressourcen

https://submissions.mirasmart.com/ISMRM2022/Itinerary/ConferenceMatrixEventDetail.aspx?id=151
(Zusammenfassung)

Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Roig, E., De Feyter, H., Nixon, T., Ruhm, L., Avdievich, N., Henning, A., et al. (2022). Deuterium Metabolic Imaging of the Human Brain in vivo at 7T. In Joint Annual Meeting ISMRM-ESMRMB & ISMRT 31st Annual Meeting (ISMRM 2022).


Zitierlink: https://hdl.handle.net/21.11116/0000-000A-5C8F-F
Zusammenfassung
Brain energy metabolism, for which glucose is the main fuel, is essential not only for normal brain function but also for its active role in the mechanisms that underly brain diseases. Deuterium Metabolic Imaging (DMI) is a promising MR modality for investigating whole brain energy metabolism in humans at ultra-high field. In this study, we explore the potential of DMI in the human brain in vivo at 7T. We present whole brain 3D DMI maps of well-resolved deuterated (2H) metabolite resonances of water, glucose and glutamate/glutamine (Glx) following oral administration of [6,6’-2H2]-labelled glucose.